Safety and Efficacy of Eltrombopag at Escalated Doses

NCT01880047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia
Platelet Disorder

Interventions

DRUG: Eltrombopag
DRUG: Placebo

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]